The COLOSSUS Project
Colorectal cancer is the third most common cancer in Europe. COLOSSUS is an EU-funded H2020 project that aims to provide new and more effective ways to classify patients with a specific type of colorectal cancer (microsatellite stable RAS mutant metastatic colorectal cancer or MSS RAS mt mCRC) and to develop better treatments for them. Our ultimate goal is to deliver a personalised medicine approach for patients with MSS RAS mt mCRC that is currently not available.
Project Partners
The COLOSSUS Project brings together a multidisciplinary team of 14 different partners from 8 different countries.
Latest News
Congratulations U of Torino PIs who published two more COLOSSUS papers!
Congratulations to all researchers involved in two COLOSSUS-acknowledged publications! The first, Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga, appears in the December 2019 edition of Trends in Cancer. The piece was [...]
Congratulations to Coordinator Prof Annette Byrne, RCSI for her recent HRB Investigator-Led Projects Award
Professor Annette Byrne was one of eight RCSI researchers to have been awarded a total of €2.8m in the 2019 Health Research Board (HRB) Investigator-Led Projects funding programme. Congratulations, Annette! The HRB Investigator-Led Projects scheme [...]
Vall d’Hebron recruits the first COLOSSUS translational trial participant in Spain
Pictured (from L to R) Iosune Baraibar, medical oncologist; Mireia Sanchis, Project Manager; Ariadna Garcia, Research Nurse; Javier Ros, Medical Oncologist; Javier Gonzalo, Project Manager* On November 5, 2019, Dr Rodrigo Dienstmann and the colorectal cancer clinical research team under [...]